down arrow

Porton Pharma Solutions Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001S57
CNY
23.13
-0.06 (-0.26%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Porton Pharma Solutions Ltd.
Why is Porton Pharma Solutions Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.09% and Operating profit at -172.67% over the last 5 years
2
With a growth in Operating Profit of 584.82%, the company declared Very Positive results in Mar 25
  • NET SALES(9M) At CNY 2,442.54 MM has Grown at 23.04%
  • RAW MATERIAL COST(Y) Fallen by -182.25% (YoY)
  • PRE-TAX PROFIT(Q) Highest at CNY -0.17 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 18.92%, its profits have risen by 59.7%
  • At the current price, the company has a high dividend yield of 0
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Porton Pharma Solutions Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Porton Pharma Solutions Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Porton Pharma Solutions Ltd.
28.43%
1.59
54.01%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.09%
EBIT Growth (5y)
-172.67%
EBIT to Interest (avg)
26.30
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.53
Tax Ratio
14.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.03%
ROE (avg)
11.26%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.36
EV to EBIT
-271.88
EV to EBITDA
41.98
EV to Capital Employed
2.32
EV to Sales
3.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.85%
ROE (Latest)
-3.03%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
NET SALES(9M)

At CNY 2,442.54 MM has Grown at 23.04%

RAW MATERIAL COST(Y)

Fallen by -182.25% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY -0.17 MM

NET PROFIT(Q)

Highest at CNY -4.28 MM

EPS(Q)

Highest at CNY -0.01

-2What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 20.04 %

Here's what is working for Porton Pharma Solutions Ltd.
Net Sales
At CNY 1,675.94 MM has Grown at 28.97%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit
Highest at CNY -0.17 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit
At CNY -0.17 MM has Grown at 99.87%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY -4.28 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit
At CNY -4.28 MM has Grown at 95.48%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY -0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost
Fallen by -182.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Porton Pharma Solutions Ltd.
Debt-Equity Ratio
Highest at 20.04 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."